Cutanogen Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Cutanogen General Information

Description

Provider of biotechnology services. The company focuses on products such as PermaDerm and has license to develop engineered skin substitutes that are used to treat patients with severe burns.

Contact Information

Website
www.cutanogen.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3130 Highland Avenue
  • Suite 3420
  • Cincinnati, OH 45219
  • United States
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Amarantus BioScience Holdings
Vertical(s)
Life Sciences
Corporate Office
  • 3130 Highland Avenue
  • Suite 3420
  • Cincinnati, OH 45219
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cutanogen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cutanogen‘s full profile, request access.

Request a free trial

Cutanogen Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cutanogen‘s full profile, request access.

Request a free trial

Cutanogen FAQs

  • When was Cutanogen founded?

    Cutanogen was founded in 1997.

  • Who is the founder of Cutanogen?

    Steven Boyce is the founder of Cutanogen.

  • Where is Cutanogen headquartered?

    Cutanogen is headquartered in Cincinnati, OH.

  • What industry is Cutanogen in?

    Cutanogen’s primary industry is Biotechnology.

  • Is Cutanogen a private or public company?

    Cutanogen is a Private company.

  • What is the current valuation of Cutanogen?

    The current valuation of Cutanogen is 000.

  • What is Cutanogen’s current revenue?

    The current revenue for Cutanogen is 00000.

  • Who are Cutanogen’s investors?

    Lonza Group has invested in Cutanogen.

  • When was Cutanogen acquired?

    Cutanogen was acquired on 15-Jul-2015.

  • Who acquired Cutanogen?

    Cutanogen was acquired by Amarantus BioScience Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »